Schedule 13G ownership disclosure

PEREGRINE PHARMACEUTICALS INC COM NEW

Security class unavailable · CUSIP: 713661502

Event date: 2017-11-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,829,504
Percent of class
8.4900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-17-005419
Form type
SC 13G/A
Filer
Avid Bioservices, Inc.
CIK
CIK 704562
Filed
Nov 13, 2017
Reporting period
Nov 06, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub